Table 5.
Incremental cost-effective ratio estimates for 3GIRS versus standard interventions
| Programme | Year(s) | Cost per case averted | Cost per death averted (USD) | Cost per DALY averted (USD) | Cost-effectiveness estimate | Stringent highly cost-effective threshold (0.5 × GDP per capita)a (USD) | WHO highly cost-effective threshold (GDP per capita)a (USD) | WHO cost-effective threshold (3 × GDP per capita)a (USD) |
|---|---|---|---|---|---|---|---|---|
|
Ghana AIRS/VectorLink Northeastern and Northern Regions |
2017–2018 | 3.20 | 1599 | 48 | Highly cost-effective (by stringent standard) | 1130 | 2260 | 6780 |
|
Mali AIRS/VectorLink Mopti Region |
2017 | 6.76 | 3380 | 102 | Highly cost-effective (by stringent standard) | 467 | 933 | 2700 |
|
Uganda Abt bilateral Northern and Eastern Regions |
2017–2018 | 41.25 | 20,624 | 625 | Highly cost-effective (by WHO standard) | 380 | 759 | 2277 |
|
Zambia AIRS/VectorLink Eastern, Luapula, Muchinga, Northern Provinces |
2017 | 105.15 | 52,572 | 1593 | Cost-effective | 670 | 1340 | 4020 |
3GIRS, third-generation indoor residual spray; AIRS, Africa Indoor Residual Spraying Project; DALY, disability-adjusted life year; GDP, gross domestic product; USD, US dollars; WHO, World Health Organization
aGDP per capita extracted from International Monetary Fund’s World Economic Outlook